CS190340B2 - Method of producing 1-terc.-butylamino-3-/2,5-dichlorphenoxy/2-propanole - Google Patents

Method of producing 1-terc.-butylamino-3-/2,5-dichlorphenoxy/2-propanole

Info

Publication number
CS190340B2
CS190340B2 CS771363A CS136377A CS190340B2 CS 190340 B2 CS190340 B2 CS 190340B2 CS 771363 A CS771363 A CS 771363A CS 136377 A CS136377 A CS 136377A CS 190340 B2 CS190340 B2 CS 190340B2
Authority
CS
Czechoslovakia
Prior art keywords
dichlorphenoxy
propanole
terc
butylamino
producing
Prior art date
Application number
CS771363A
Other languages
Czech (cs)
English (en)
Inventor
Andor Hajos
Marton Fekete
Marianna Kuerti
Tibor Lang
Lajos Toldy
Janos Borvendeg
Laszlo Nagy
Sandor Elek
Istvan Polgari
Istvan Elekes
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of CS190340B2 publication Critical patent/CS190340B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CS771363A 1976-03-02 1977-03-01 Method of producing 1-terc.-butylamino-3-/2,5-dichlorphenoxy/2-propanole CS190340B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76GO00001331A HU172137B (hu) 1976-03-02 1976-03-02 Sposob poluchenija zamehhjonnykh proizvodnykh fenoksi-propanolamina

Publications (1)

Publication Number Publication Date
CS190340B2 true CS190340B2 (en) 1979-05-31

Family

ID=10996805

Family Applications (1)

Application Number Title Priority Date Filing Date
CS771363A CS190340B2 (en) 1976-03-02 1977-03-01 Method of producing 1-terc.-butylamino-3-/2,5-dichlorphenoxy/2-propanole

Country Status (25)

Country Link
US (1) US4310549A (fr)
JP (1) JPS5923299B2 (fr)
AT (1) AT348507B (fr)
AU (1) AU508766B2 (fr)
BE (1) BE851938A (fr)
CA (1) CA1091254A (fr)
CH (1) CH627732A5 (fr)
CS (1) CS190340B2 (fr)
DD (1) DD128610A5 (fr)
DE (1) DE2709109C3 (fr)
DK (1) DK143554C (fr)
FI (1) FI65231C (fr)
FR (1) FR2342956A1 (fr)
GB (1) GB1573191A (fr)
HU (1) HU172137B (fr)
IL (1) IL51574A (fr)
IN (1) IN144243B (fr)
KE (1) KE3340A (fr)
MY (1) MY8500104A (fr)
NL (1) NL7702170A (fr)
NO (1) NO141989C (fr)
PL (1) PL103734B1 (fr)
SE (1) SE440647B (fr)
SU (1) SU648080A3 (fr)
YU (1) YU40813B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
WO2008020314A2 (fr) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Formulations de dosage stabilisantes à base de statine
WO2008010087A2 (fr) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited FORMES POLYMORPHES D'UN INHIBITEUR DE LA HMG-CoA-RÉDUCTASE ET LEURS UTILISATIONS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569692A5 (fr) 1971-03-17 1975-11-28 Richter Gedeon Vegyeszet
US4067904A (en) * 1975-12-19 1978-01-10 Mead Johnson & Company Alkylsulfonylphenoxypropanolamine derivatives

Also Published As

Publication number Publication date
IL51574A0 (en) 1977-05-31
GB1573191A (en) 1980-08-20
HU172137B (hu) 1978-06-28
PL103734B1 (pl) 1979-07-31
ATA134177A (de) 1978-07-15
DK143554B (da) 1981-09-07
FI65231C (fi) 1984-04-10
YU40813B (en) 1986-06-30
AU508766B2 (en) 1980-04-03
FI770651A (fr) 1977-09-03
SE7702251L (sv) 1977-09-03
NO770688L (no) 1977-09-05
NO141989C (no) 1980-06-11
CA1091254A (fr) 1980-12-09
DE2709109A1 (de) 1977-09-15
NO141989B (no) 1980-03-03
US4310549A (en) 1982-01-12
AT348507B (de) 1979-02-26
IN144243B (fr) 1978-04-15
YU54977A (en) 1982-10-31
DD128610A5 (de) 1977-11-30
MY8500104A (en) 1985-12-31
FI65231B (fi) 1983-12-30
KE3340A (en) 1983-11-25
DK143554C (da) 1982-03-08
IL51574A (en) 1980-01-31
FR2342956B1 (fr) 1982-11-26
CH627732A5 (de) 1982-01-29
FR2342956A1 (fr) 1977-09-30
SU648080A3 (ru) 1979-02-15
DE2709109B2 (de) 1980-01-17
DK88577A (da) 1977-09-03
JPS52122328A (en) 1977-10-14
JPS5923299B2 (ja) 1984-06-01
DE2709109C3 (de) 1980-09-18
AU2279577A (en) 1978-09-07
SE440647B (sv) 1985-08-12
BE851938A (fr) 1977-09-01
NL7702170A (nl) 1977-09-06

Similar Documents

Publication Publication Date Title
CS191329B2 (en) Method of producing m-phenoxybenzaldehyde
JPS5343021A (en) Method of producing molybdenummiron
JPS5289610A (en) Method of producing 3*33dimethll22oxoobutyrate
SU725557A3 (en) Method of preparing 1,2,3-thiadiazol-5-yl-ureas
CS190340B2 (en) Method of producing 1-terc.-butylamino-3-/2,5-dichlorphenoxy/2-propanole
CS194827B2 (en) Method of producing 2-chlor-4,6-bis-alkylamino-s-triazines
GB1554095A (en) Method of producing 5-nitroso-2,4,6-triaminopyrimidine
JPS5328106A (en) Method of producing 22alkyll22methylpropanee 1*33diol
JPS5384981A (en) Method of producing 11*tetrahydroo22furanyl**55 fluorouracile
IL52643A0 (en) Method of preparing 2,3-dichloroanisole
JPS5318414A (en) Method of producing tangstennbased parts
CS193596B2 (en) Method of producing 1,1-dihalogene-4-methyl-1,3-pentadiene
JPS52128380A (en) Method of producing 22chloronicotinamides
JPS5378229A (en) Method of producing canthaxanthene
CS189980B1 (en) Method of producing 1,5-endomethylen-3,7-dinitroso-1,3,5,7-tetraazacyclooctane
CS189214B1 (en) Method of producing 1,5-endomethylen-3,7-dinitroso-1,3,5,5,7-tetraazacyclooctane
PT65198B (en) Method of producing 2,6-ditertbutyl-4-methylphenol
CS184527B1 (en) Method of producing 3',5'-di-0-benzoyl-2'-deoxy-5-fluoruridine
JPS52131511A (en) Method of producing 33deoxyy33iodooddglucose
JPS52122314A (en) Method of producing 33deoxyy33iodooddglucose
JPS52108504A (en) Method of producing turboofans
JPS5328111A (en) Method of producing dimethlheptenone
CS188279B2 (en) Method of producing new 9-alkylaminoerythromycines
CS184254B1 (en) Method of producing 2-methyl-3-oxo-4,5-dimethoxy-2h-pyridazine
CS184280B1 (en) Method of producing 1,5-cyclooctadiene